Plerixafor Injection, Solution
Product Images NDC 65219-284

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Plerixafor (NDC 65219-284). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1: Structural Formula (Plerixafor 01)

Figure 1: Structural Formula (Plerixafor 01)
Chemical structure of plerixafor, showing two macrocyclic nitrogen-containing rings connected by a benzene ring in the center. The image depicts the molecular framework of the active ingredient in Plerixafor injection.*
FDA Label Image

Principal Display Panel (24 mg/1.2 mL Vial Label)

Principal Display Panel (24 mg/1.2 mL Vial Label)
Label for Plerixafor injection, 24 mg/1.2 mL (20 mg/mL) solution for subcutaneous injection, Rx only. Manufactured for Fresenius Kabi USA, LLC, Lake Zurich, IL. Includes NDC 65219-9284-12, barcode, and space for lot and expiration dates.*
FDA Label Image

Principal Display Panel (24 mg/1.2 mL Vial Carton)

Principal Display Panel (24 mg/1.2 mL Vial Carton)
Packaging label for Plerixafor injection 24 mg/1.2 mL (20 mg/mL) by Fresenius Kabi USA, LLC. The label indicates this is a subcutaneous injection in a single-dose vial with no preservatives. Storage instructions specify 25°C (77°F) with permitted excursions between 15°-30°C (59°-86°F). The label includes NDC 65219-28412 and a barcode, and details formulation components and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.